12 Health Care Stocks Moving In Friday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Friday's intraday session, several health care stocks showed significant movement. Biodexa Pharmaceuticals, Agenus, Sunshine Biopharma, Cullinan Therapeutics, ImmunityBio, and Zura Bio were among the gainers with notable percentage increases in their stock prices. Conversely, Nuwellis, IMAC Holdings, NKGen Biotech, Aclarion, Accolade, and X4 Pharmaceuticals experienced declines. Accolade's drop was highlighted alongside its Q4 earnings report release.
April 26, 2024 | 4:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Accolade's stock declined by 14.86% to $7.83, following its Q4 earnings report.
The decline in ACCD's stock price post-Q4 earnings suggests the market's negative reaction to the earnings report, impacting investor sentiment.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 95
NEGATIVE IMPACT
Nuwellis shares decreased by 39.5% to $0.17, with a market value of $1.1 million.
The sharp decline in NUWE's stock price indicates negative market sentiment or reactions, potentially due to unfavorable company developments.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Agenus shares rose 32.53% to $11.0, with a market value of $230.4 million.
Agenus's significant stock price increase could reflect positive market sentiment or reactions to company news, driving investor interest.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
Biodexa Pharmaceuticals stock rose 61.4% to $1.17, with a market cap of $5.1 million.
The significant rise in BDRX's stock price indicates strong investor interest, potentially due to positive company developments or market reactions.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90